Tech Company Financing Transactions

Paratek Pharmaceuticals Funding Round

Paratek Pharmaceuticals secured a $662 thousand financing round on 3/31/2014. Investors included Aisling Capital.

Transaction Overview

Announced On
3/31/2014
Transaction Type
Venture Equity
Amount
$662,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
75 Kneeland St. 4th Floor
Boston, MA 02111
USA
Email Address
Overview
Paratek Pharmaceuticals, Inc. is a privately held biopharmaceutical company headquartered in Boston, MA, which is engaged in the discovery and commercialization of new therapeutics that treat life threatening infectious and other serious diseases.
Profile
Paratek Pharmaceuticals LinkedIn Company Profile
Social Media
Paratek Pharmaceuticals Company Twitter Account
Company News
Paratek Pharmaceuticals News
Facebook
Paratek Pharmaceuticals on Facebook
YouTube
Paratek Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Michael Bigham
  Michael Bigham LinkedIn Profile  Michael Bigham Twitter Account  Michael Bigham News  Michael Bigham on Facebook
Chief Financial Officer
Douglas Pagán
  Douglas Pagán LinkedIn Profile  Douglas Pagán Twitter Account  Douglas Pagán News  Douglas Pagán on Facebook
Chief Operating Officer
Adam Woodrow
  Adam Woodrow LinkedIn Profile  Adam Woodrow Twitter Account  Adam Woodrow News  Adam Woodrow on Facebook
President
Evan Loh
  Evan Loh LinkedIn Profile  Evan Loh Twitter Account  Evan Loh News  Evan Loh on Facebook
VP - Bus. Development
Evan Tzanis
  Evan Tzanis LinkedIn Profile  Evan Tzanis Twitter Account  Evan Tzanis News  Evan Tzanis on Facebook
VP - General Counsel
William Haskel
  William Haskel LinkedIn Profile  William Haskel Twitter Account  William Haskel News  William Haskel on Facebook
VP - Human Resources
Regina Paglia
  Regina Paglia LinkedIn Profile  Regina Paglia Twitter Account  Regina Paglia News  Regina Paglia on Facebook
VP - Regulatory Affairs
Randy Brenner
  Randy Brenner LinkedIn Profile  Randy Brenner Twitter Account  Randy Brenner News  Randy Brenner on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2014: Audax Health venture capital transaction
Next: 3/31/2014: Everactive venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to record every notable VC transaction. All VC database entries on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary